Health Condition 1: null- Keratoconus
Conditions
Interventions
Intervention1: Timolol: Timolol is a Ã?-adrenergic blocking agent, successfully used for treating glaucoma. It is available both as an ophthalmic solution (0.25% or 0.5%) typically administered twice
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: Patients between 15 to 30 years of age with a definitive diagnosis of keratoconus as in accordance with guidelines of Collaborative Longitudinal Evaluation of Keratoconus Group
Exclusion criteria
Exclusion criteria: Patients with associated ocular surface disease Systemic disorders like bronchial asthma cardiovascular disorders Pre existing glaucoma or use of antiglaucoma drugs H/o prior treatment with collagen cross linking H/o prior corneal hydrops History of use of contact lens in the last 3 weeks Pregnancy or lactation during the period of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Corneal tomographyTimepoint: Baseline (Day 0), Month 3, and Month 6. | — |
Secondary
| Measure | Time frame |
|---|---|
| Best spectacle-corrected Visual Acuity (BSCVA)Timepoint: Baseline (Day 0), Month 3, and Month 6.;Fundus and optic nerve head evaluationTimepoint: Baseline (Day 0), Month 3, and Month 6.;Intraocular pressureTimepoint: Baseline (Day 0), Month 3, and Month 6.;Manifest refractionTimepoint: Baseline (Day 0), Month 3, and Month 6.;Slit lamp biomicroscopyTimepoint: Baseline (Day 0), Month 3, and Month 6.;Uncorrected Visual Acuity (UCVA)Timepoint: Baseline (Day 0), Month 3, and Month 6. | — |
Countries
India
Contacts
Public ContactDr Pravin V Krishna
LV Prasad Eye InstituteÂ
Outcome results
None listed